| A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design F Sacca, G Puorro, A Antenora, A Marsili, A Denaro, R Piro, P Sorrentino, ... PLoS One 6 (3), e17627, 2011 | 79 | 2011 |
| A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results F Saccà, M Quarantelli, C Rinaldi, T Tucci, R Piro, G Perrotta, ... Journal of neurology 259, 132-138, 2012 | 62 | 2012 |
| Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit F Saccà, R Piro, G De Michele, F Acquaviva, A Antenora, G Carlomagno, ... Movement Disorders 26 (4), 739-742, 2011 | 54 | 2011 |
| A randomized clinical trial of lithium in multiple system atrophy F Saccà, A Marsili, M Quarantelli, V Brescia Morra, A Brunetti, R Carbone, ... Journal of neurology 260, 458-461, 2013 | 46 | 2013 |
| Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene F Saccà, A Marsili, G Puorro, A Antenora, C Pane, A Tessa, ... Journal of neurology 260, 1116-1121, 2013 | 32 | 2013 |
| Steroid treatment in Ataxia-Telangiectasia induces alterations of functional magnetic resonance imaging during prono-supination task M Quarantelli, G Giardino, A Prinster, G Aloj, B Carotenuto, E Cirillo, ... european journal of paediatric neurology 17 (2), 135-140, 2013 | 26 | 2013 |
